Macromed Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 13 Year, 4 Days
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -5.25%
- Profit Growth 1.19%
- Ebitda -10.12%
- Net Worth 64.10%
- Total Assets 10.31%
About Macromed Pharmaceuticals
Macromed Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 February 2012 and has a history of 13 years. Its registered office is in Villupuram, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Pugazhendi Lakshmanan and Monisha serve as directors at the Company.
Company Details
- Location
Villupuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232PY2012PTC002680
- Company No.
002680
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2012
- Date of AGM
30 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
Who are the key members and board of directors at Macromed Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pugazhendi Lakshmanan  | Managing Director | 21-Feb-2012 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Monisha | Additional Director | 06-Sep-2023 | Current |
Financial Performance of Macromed Pharmaceuticals.
Macromed Pharmaceuticals Private Limited, for the financial year ended 2018, experienced Minor drop in revenue, with a 5.25% decrease. The company also saw a slight improvement in profitability, with a 1.19% increase in profit. The company's net worth Soared by an impressive increase of 64.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Macromed Pharmaceuticals?
In 2018, Macromed Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Spgb Chemicals Private LimitedPugazhendi Lakshmanan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Macromed Pharmaceuticals?
Macromed Pharmaceuticals has a workforce of 2 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Macromed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Macromed Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
